Citadel Advisors
BMRN icon

Citadel Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.4M Sell
335,020
-1,260,038
-79% -$69.3M ﹤0.01% 1007
2025
Q1
$113M Buy
1,595,058
+1,207,445
+312% +$85.4M 0.02% 226
2024
Q4
$25.5M Sell
387,613
-816,784
-68% -$53.7M ﹤0.01% 819
2024
Q3
$84.7M Buy
1,204,397
+646,545
+116% +$45.4M 0.02% 290
2024
Q2
$45.9M Sell
557,852
-1,417,706
-72% -$117M 0.01% 514
2024
Q1
$173M Buy
1,975,558
+1,620,613
+457% +$142M 0.03% 120
2023
Q4
$34.2M Buy
354,945
+213,413
+151% +$20.6M 0.01% 617
2023
Q3
$12.5M Sell
141,532
-340,807
-71% -$30.2M ﹤0.01% 1023
2023
Q2
$41.8M Buy
482,339
+358,771
+290% +$31.1M 0.01% 485
2023
Q1
$12M Sell
123,568
-6,933
-5% -$674K ﹤0.01% 1184
2022
Q4
$13.5M Sell
130,501
-871,813
-87% -$90.2M ﹤0.01% 1101
2022
Q3
$85M Sell
1,002,314
-150,761
-13% -$12.8M 0.02% 218
2022
Q2
$95.6M Sell
1,153,075
-937,328
-45% -$77.7M 0.02% 173
2022
Q1
$161M Buy
2,090,403
+732,488
+54% +$56.5M 0.03% 100
2021
Q4
$120M Buy
1,357,915
+1,308,848
+2,667% +$116M 0.02% 159
2021
Q3
$3.79M Sell
49,067
-911,095
-95% -$70.4M ﹤0.01% 2312
2021
Q2
$80.1M Sell
960,162
-673,518
-41% -$56.2M 0.02% 311
2021
Q1
$123M Sell
1,633,680
-1,361,590
-45% -$103M 0.03% 166
2020
Q4
$263M Buy
2,995,270
+517,914
+21% +$45.4M 0.07% 47
2020
Q3
$188M Buy
2,477,356
+2,222,384
+872% +$169M 0.05% 63
2020
Q2
$31.4M Sell
254,972
-4,355
-2% -$537K 0.01% 566
2020
Q1
$21.9M Sell
259,327
-1,780,826
-87% -$150M 0.01% 639
2019
Q4
$172M Buy
2,040,153
+282,923
+16% +$23.9M 0.07% 87
2019
Q3
$118M Buy
1,757,230
+587,616
+50% +$39.6M 0.06% 162
2019
Q2
$100M Buy
1,169,614
+40,966
+4% +$3.51M 0.05% 204
2019
Q1
$100M Sell
1,128,648
-229,037
-17% -$20.3M 0.05% 179
2018
Q4
$116M Sell
1,357,685
-1,101,023
-45% -$93.8M 0.06% 122
2018
Q3
$238M Buy
2,458,708
+625,303
+34% +$60.6M 0.11% 67
2018
Q2
$173M Buy
1,833,405
+457,896
+33% +$43.1M 0.09% 98
2018
Q1
$112M Sell
1,375,509
-939,566
-41% -$76.2M 0.06% 145
2017
Q4
$206M Buy
2,315,075
+671,639
+41% +$59.9M 0.13% 79
2017
Q3
$153M Buy
1,643,436
+1,401,415
+579% +$130M 0.12% 79
2017
Q2
$22M Sell
242,021
-224,884
-48% -$20.4M 0.02% 573
2017
Q1
$41M Sell
466,905
-233,832
-33% -$20.5M 0.04% 342
2016
Q4
$58M Sell
700,737
-272,548
-28% -$22.6M 0.06% 171
2016
Q3
$90M Sell
973,285
-680,698
-41% -$63M 0.09% 111
2016
Q2
$129M Sell
1,653,983
-540,892
-25% -$42.1M 0.14% 63
2016
Q1
$181M Buy
2,194,875
+2,121,458
+2,890% +$175M 0.23% 26
2015
Q4
$7.69M Sell
73,417
-353,165
-83% -$37M 0.01% 937
2015
Q3
$44.9M Sell
426,582
-153,235
-26% -$16.1M 0.04% 371
2015
Q2
$79.3M Sell
579,817
-385,389
-40% -$52.7M 0.07% 242
2015
Q1
$120M Sell
965,206
-492,997
-34% -$61.4M 0.11% 144
2014
Q4
$132M Buy
1,458,203
+256,311
+21% +$23.2M 0.13% 97
2014
Q3
$86.7M Buy
1,201,892
+634,138
+112% +$45.8M 0.09% 168
2014
Q2
$35.3M Sell
567,754
-69,792
-11% -$4.34M 0.04% 385
2014
Q1
$43.5M Buy
637,546
+89,804
+16% +$6.13M 0.05% 344
2013
Q4
$38.5M Buy
547,742
+80,715
+17% +$5.67M 0.05% 344
2013
Q3
$33.7M Sell
467,027
-419,963
-47% -$30.3M 0.05% 361
2013
Q2
$49.5M Buy
+886,990
New +$49.5M 0.09% 226